KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Payables (2017 - 2025)

Historic Payables for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to $12.5 million.

  • Twist Bioscience's Payables rose 6650.67% to $12.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $12.5 million, marking a year-over-year increase of 6650.67%. This contributed to the annual value of $11.1 million for FY2025, which is 58061.35% up from last year.
  • As of Q4 2025, Twist Bioscience's Payables stood at $12.5 million, which was up 6650.67% from $11.1 million recorded in Q3 2025.
  • Twist Bioscience's 5-year Payables high stood at $23.1 million for Q4 2021, and its period low was $1.6 million during Q3 2024.
  • Over the past 5 years, Twist Bioscience's median Payables value was $12.0 million (recorded in 2025), while the average stood at $12.5 million.
  • In the last 5 years, Twist Bioscience's Payables plummeted by 5398.0% in 2023 and then soared by 58061.35% in 2025.
  • Over the past 5 years, Twist Bioscience's Payables (Quarter) stood at $23.1 million in 2021, then decreased by 12.83% to $20.1 million in 2022, then tumbled by 53.98% to $9.3 million in 2023, then fell by 18.94% to $7.5 million in 2024, then skyrocketed by 66.51% to $12.5 million in 2025.
  • Its Payables stands at $12.5 million for Q4 2025, versus $11.1 million for Q3 2025 and $12.0 million for Q2 2025.